Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL23826

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
[N-]=[N+]=Nc1cccc(CNCCCCNCc2cccc(N=[N+]=[N-])c2)c1

Basic Information

ChEMBL ID CHEMBL23826
Phase Preclinical
Structure Type MOL
InChI Key MHYNYULJPBTDCS-UHFFFAOYSA-N
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

350.4
MW (Da)
5.23
ALogP
4
HBA
2
HBD
121.6
PSA (Ų)
0.25
QED
1
Ro5 Violations
11
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C18H22N8
MW 350.43
Aromatic Rings 2
Heavy Atoms 26
NP-Likeness -0.46

Activity Summary

IC50 2 meas. best 4.82

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
PC-3
CHEMBL390
IC50 4.82 4.82 15000.0 1
MDA-MB-231
CHEMBL400
IC50 4.72 4.72 19000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
PC-3 IC50 = 15000.0 nM 4.82 Inhibition of human prostate cancer cell line PC-3 growth 11965367
MDA-MB-231 IC50 = 19000.0 nM 4.72 Inhibition of human breast cancer cell line MDA-MB-231 growth 11965367

Literature References

PubMed DOI Target Context # Activities
11965367 10.1016/s0960-894x(02)00156-7 MDA-MB-231 1
11965367 10.1016/s0960-894x(02)00156-7 PC-3 1

Data from ChEMBL 36 via Core Engine